# the Effect of ABCC2 Genetic Polymorphism on Neurotoxicity in Gastrointestinal Cancer Patients Receiving Oxaliplatin

> **NCT05494320** · — · UNKNOWN · sponsor: **Ain Shams University** · enrollment: 120 (estimated)

## Conditions studied

- Gastrointestinal Cancer

## Interventions

- **DRUG:** Folfox Protocol

## Key facts

- **NCT ID:** NCT05494320
- **Lead sponsor:** Ain Shams University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-08-15
- **Primary completion:** 2022-08-05
- **Final completion:** 2022-12-31
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2022-08-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05494320

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05494320, "the Effect of ABCC2 Genetic Polymorphism on Neurotoxicity in Gastrointestinal Cancer Patients Receiving Oxaliplatin". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05494320. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*